Literature DB >> 10924611

An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease.

S A Campbell1, R S Shirey, K E King, P M Ness.   

Abstract

BACKGROUND: A hemolytic transfusion reaction (HTR) due to anti-IH is reported in a patient with sickle cell disease (SCD). CASE REPORT: An 18-year-old woman with SCD and a complete phenotype on file had been identified as group B-positive with negative antibody-screening tests and had received 1 unit of packed RBCs. Ten days later, she was readmitted in painful crisis with a Hb of 4.2 g per dL. Antibody-screening tests and panel cells were positive at all test phases with a negative autocontrol, which suggested alloantibodies. Phenotypically matched group O RBCs were issued emergently. After the transfusion of 100 mL, the patient had an HTR with chills, fever, and tachycardia and laboratory findings of hemoglobinemia, hemoglobinuria, and negative DATs. A high-titer, IgM anti-IH with a high thermal amplitude (reactive with group O, but not group B RBCs at 37 degrees C) was identified. Autologous RBCs appeared to have normal I antigen expression, but less H antigen than pooled group B RBCs. She was given group B RBCs, uneventfully, by use of a blood warmer.
CONCLUSIONS: This is a rare case of anti-IH as the cause of a HTR, as a serologic problem that may be seen in SCD, and as an autoantibody that may mimic an alloantibody. Ironically, this HTR resulted from the effort to provide phenotypically matched RBCs, which necessitated the selection of group O RBCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924611     DOI: 10.1046/j.1537-2995.2000.40070828.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Incidental Discovery of Anti-IH in a Patient Planned for Caesarean Section and it's Repercussions.

Authors:  Lin-Nan Shao; Wen-Qian Song; Ni Wang; Wei-Jian Yu; Shi-Hang Zhou
Journal:  Indian J Hematol Blood Transfus       Date:  2017-11-18       Impact factor: 0.900

Review 2.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

3.  A Very Rare Case with Particular H-deficient Phenotypes.

Authors:  Min Song; Shuming Zhao; Tianlun Jiang; Hua Lu
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-11       Impact factor: 0.900

4.  Anti IH: An antibody worth mention.

Authors:  Nithya Mohanan; Nittin Henry; Aboobacker Mohamed Rafi; Susheela J Innah
Journal:  Asian J Transfus Sci       Date:  2016 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.